Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Cowan

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|April 23, 2023
Nanobody inhibitors of Plexin-B1 identify allostery in plexin-semaphorin interactions and signalingRichard Cowan, Martina Trokter, Arkadiusz Oleksy, et al.
Clinical Prostate Cancer|October 4, 2005
Safety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancerRobert E Hawkins, Luc Daigneault, Richard Cowan, et al.
Acta Oncologica (Stockholm, Sweden)|August 27, 2025
Radiation exposure of breast tissue in lymphoma radiotherapy: a systematic review of breast dose metrics published since 2000Hannah Chamberlin, Georgios Ntentas, David J Cutter, et al.
American Journal of Clinical Dermatology|November 18, 2022
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel DiscussionEmmilia Hodak, Larisa Geskin, Emmanuella Guenova, et al.
American Journal of Clinical Dermatology|March 14, 2023
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel DiscussionEmmilia Hodak, Larisa Geskin, Emmanuella Guenova, et al.
Prostate Cancer|July 14, 2012
Dose-escalated hypofractionated intensity-modulated radiotherapy in high-risk carcinoma of the prostate: outcome and late toxicityDavid Thomson, Sophie Merrick, Ric Swindell, et al.
Plos One|July 17, 2023
Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic toolKovilen Sawmynaden, Nicholas Wong, Sarah Davies, et al.
Molecular Psychiatry|November 15, 2021
Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer's diseasePreeti Bakrania, Gareth Hall, Yvonne Bouter, et al.
The Lancet. Oncology|September 3, 2021
The UK's contribution to cancer control in low-income and middle-income countriesSusannah Stanway, Mark Lodge, Richard Sullivan, et al.
The Journal of Biological Chemistry|May 28, 2016
Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIESGareth Hall, Eilish Cullen, Kovilen Sawmynaden, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|April 23, 2023
Nanobody inhibitors of Plexin-B1 identify allostery in plexin-semaphorin interactions and signalingRichard Cowan, Martina Trokter, Arkadiusz Oleksy, et al.
Clinical Prostate Cancer|October 4, 2005
Safety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancerRobert E Hawkins, Luc Daigneault, Richard Cowan, et al.
Acta Oncologica (Stockholm, Sweden)|August 27, 2025
Radiation exposure of breast tissue in lymphoma radiotherapy: a systematic review of breast dose metrics published since 2000Hannah Chamberlin, Georgios Ntentas, David J Cutter, et al.
American Journal of Clinical Dermatology|November 18, 2022
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel DiscussionEmmilia Hodak, Larisa Geskin, Emmanuella Guenova, et al.
American Journal of Clinical Dermatology|March 14, 2023
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel DiscussionEmmilia Hodak, Larisa Geskin, Emmanuella Guenova, et al.
Prostate Cancer|July 14, 2012
Dose-escalated hypofractionated intensity-modulated radiotherapy in high-risk carcinoma of the prostate: outcome and late toxicityDavid Thomson, Sophie Merrick, Ric Swindell, et al.
Plos One|July 17, 2023
Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic toolKovilen Sawmynaden, Nicholas Wong, Sarah Davies, et al.
Molecular Psychiatry|November 15, 2021
Discovery of a novel pseudo β-hairpin structure of N-truncated amyloid-β for use as a vaccine against Alzheimer's diseasePreeti Bakrania, Gareth Hall, Yvonne Bouter, et al.
The Lancet. Oncology|September 3, 2021
The UK's contribution to cancer control in low-income and middle-income countriesSusannah Stanway, Mark Lodge, Richard Sullivan, et al.
The Journal of Biological Chemistry|May 28, 2016
Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIESGareth Hall, Eilish Cullen, Kovilen Sawmynaden, et al.
Pageof 5